Cardiac transplantation: The final therapeutic option for the treatment of heart failure Article Report uri icon

Overview

MeSH Major

  • Heart Failure
  • Inflammation Mediators
  • Interleukin-6
  • Tumor Necrosis Factor-alpha

abstract

  • End-stage heart failure is still associated with a decrease in quality and prognosis of life. Cardiac transplantation remains the final extraordinary therapeutic option for the treatment of truly irreversible end-stage heart failure in all age groups. The selection process of candidates and the acceptance of patients with relative contra-indications is characterized by the experience and skills of an interdisciplinary transplant team, which should have access to different mechanical circulatory support systems for short-term or long-term use: bridging to transplant as well as for recovery.

publication date

  • June 13, 2000

Research

keywords

  • Report

Identity

Digital Object Identifier (DOI)

  • 10.1097/00001573-200005000-00010

PubMed ID

  • 10952425

Additional Document Info

start page

  • 178

end page

  • 82

volume

  • 15

number

  • 3